Intravesical bacillus Calmette-Guérin outcomes in patients with bladder cancer and asymptomatic bacteriuria Journal Article


Author: Herr, H. W.
Article Title: Intravesical bacillus Calmette-Guérin outcomes in patients with bladder cancer and asymptomatic bacteriuria
Abstract: The outcome of intravesical bacillus Calmette-Guérin therapy was studied in patients with asymptomatic bacteriuria. A total of 243 patients with high risk, nonmuscle invasive bladder cancer received induction intravesical bacillus Calmette-Guérin therapy. Before starting bacillus Calmette-Guérin they submitted voided urine samples for culture and were treated with bacillus Calmette-Guérin regardless of culture results without antibiotics. Patients were followed every 3 months for tumor recurrence or progression up to 2 years. Of the 243 patients 61 (25%) had significant bacteriuria (greater than 10 4 or greater than 10 5 cfu/ml single organism). Febrile urinary tract infection developed in 1 patient (1.6%) and 2 overall (0.8%) after completing induction bacillus Calmette-Guérin therapy. No patients were admitted to the hospital for bacillus Calmette-Guérin or bacterial sepsis. The 2-year recurrence-free survival rate was 71% vs 73% in uninfected patients (p = 0.73). These data suggest that intravesical bacillus Calmette-Guérin is safe in patients who have asymptomatic bacteriuria and the 2-year disease-free intervals are similar to those of uninfected patients. Such strategy facilitates the timely administration of bacillus Calmette-Guérin therapy and avoids the overuse of antibiotics. © 2012 American Urological Association Education and Research, Inc.
Keywords: adult; controlled study; treatment outcome; aged; major clinical study; cancer recurrence; cancer growth; cancer risk; follow up; bcg vaccine; bladder cancer; urinary bladder neoplasms; high risk patient; fever; cancer invasion; urinary tract infection; mycobacterium bovis; bacteriuria; urinalysis; bacterium culture; recurrence free survival; colony forming unit; asymptomatic bacteriuria; nonmuscle invasive bladder cancer; febrile urinary tract infection
Journal Title: Journal of Urology
Volume: 187
Issue: 2
ISSN: 0022-5347
Publisher: Elsevier Science, Inc.  
Date Published: 2012-02-01
Start Page: 435
End Page: 437
Language: English
DOI: 10.1016/j.juro.2011.10.032
PROVIDER: scopus
PUBMED: 22177154
DOI/URL:
Notes: --- - "Export Date: 1 March 2012" - "CODEN: JOURA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Harry W Herr
    594 Herr